Home›Search›Metabolic Syndrome and Related Disorders

Metabolic Syndrome and Related Disorders

Mary Ann Liebert Inc. · United States · Est. 1921

ISSN1540-4196eISSN1557-8518

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.548

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.587

Total Worksi

1,585

Total Citationsi

33,114

2yr Mean Citednessi

1.35

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Compiled from public sources

Metabolic Syndrome and Related Disorders is a peer-reviewed journal focused on the pathophysiology, recognition, and treatment of metabolic syndrome and related conditions. Its coverage includes insulin resistance, central obesity, glucose intolerance, dyslipidemia, hypertension, endothelial dysfunction, oxidative stress, inflammation, and disorders such as polycystic ovarian syndrome, fatty liver disease, and gout. The journal also addresses concerns in obesity, overweight, and weight loss, including research on body mass index, anthropometry, and odds ratio.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1921

FrequencySix No. A Year, 2009-

StatusActive (last: 2026)

Total Publications1,585

Publisher OrgMary Ann Liebert, Inc.

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Mary Ann Liebert Inc.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1540-4196 / 1557-8518

✅

Indexed in a trusted database?

WoS, Scopus, PubMed

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

1.5k

2019

1.6k

2020

601

2021

515

2022

404

2023

205

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Internal MedicineQ2

Endocrinology, Diabetes and MetabolismQ3

Subject Classification

Web of Science Categories

Medicine, Research & Experimental

Scopus Categories

Endocrinology, Diabetes and MetabolismInternal Medicine

Research Topics (OpenAlex)

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic DiseasesLiver Disease Diagnosis and TreatmentObesity, Physical Activity, DietDiet, Metabolism, and DiseaseDiet and metabolism studiesCardiovascular Disease and AdiposityNutrition and Health in AgingAdipose Tissue and MetabolismDiabetes Treatment and Management

Frequently asked questions about Metabolic Syndrome and Related Disorders

Is Metabolic Syndrome and Related Disorders a predatory journal?

PubScope has no integrity flags on record for Metabolic Syndrome and Related Disorders: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Metabolic Syndrome and Related Disorders?

Metabolic Syndrome and Related Disorders is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.35.

Is Metabolic Syndrome and Related Disorders indexed in Scopus and Web of Science?

Metabolic Syndrome and Related Disorders is indexed in Web of Science, Scopus.